News - Lupin

Filter

Current filters:

Lupin

Popular Filters

European Generic Medicines Association speaks out against EC’s perindopril decision

European Generic Medicines Association speaks out against EC’s perindopril decision

09-07-2014

The European Generic Medicines Association (EGA) has expressed concerns over the European Commission’s…

Cardio-vascularEuropeGenericsLegalLupinperindoprilServierunichem

Lupin no longer trying to market generics of Truvada and Viread

Lupin no longer trying to market generics of Truvada and Viread

08-06-2014

Indian drugmaker Lupin seems to have abandoned plans to bring to market generic versions of Gilead Sciences’…

Anti-viralsGenericsGilead SciencesLegalLupinPatentsTruvadaUSAViread

Lupin inks strategic biosimilars joint venture agreement with Yoshindo

23-04-2014

Indian drugmaker Lupin has entered into a strategic joint venture agreement with Japanese pharma company,…

BiosimilarsBiotechnologyEnbrelInflammatory diseasesJapanLicensingLupinTakeda PharmaceuticalYoshindo

Lupin appoints Theresa Stevens as Chief Corporate Development Officer

Lupin appoints Theresa Stevens as Chief Corporate Development Officer

23-04-2014

Pharma major Lupin has announced the appointment of Theresa Stevens as Chief Corporate Development Officer…

BoardroomLupinPharmaceuticalUSA

India’s Lupin acquires Laboratorios Grin to enter Latin American market

27-03-2014

Indian pharma major Lupin has acquired a 100% equity stake in Mexican company Laboratorios Grin, subject…

IndiaLaboratorios GrinLupinMergers & AcquisitionsMexicoOphthalmicsPharmaceutical

Lupin launches generic Niaspan in USA

24-03-2014

Indian drugmaker Lupin says that its US subsidiary has launched its niacin extended-release tablets USP,…

AbbVieCardio-vascularGenericsLupinMarkets & MarketingNiaspanNorth AmericaUSA

Mixed US court decision on ViiV Healthcare’s Epzicom and Trizivir patents

19-12-2013

UK pharma giant GlaxoSmithKline and ViiV Healthcare confirmed that the US District Court for the District…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalLupinPatentsTeva Pharmaceutical IndustriesTrizivirViiV Healthcare

Lupin in deal to market Novartis' Onbrez in India, local newspaper reports

30-07-2012

Indian drugmaker Lupin Pharmaceuticals (LOPN: BO) and Swiss major Novartis (NOVN: VX) have entered into…

Asia-PacificLicensingLupinMarkets & MarketingNovartisOnbrezPharmaceuticalRespiratory and Pulmonary

US FDA approves generics for Actavis and Lupin

06-07-2012

Switzerland-based generic drugmaker Actavis Group, now owned by US firm Watson Pharmaceuticals (NYSE:…

ActavisGenericsIntunivLupinLyricaNeurologicalNorth AmericaPfizerRegulationShireWatson Pharmaceuticals

Lupin acquires Japanese drugmaker I’rom Pharma

18-11-2011

Indian drugmaker Lupin (LOPN: BO) has entered into an agreement with Japanese health care provider I’rom…

Asia-PacificGenericsI'rom PharmaceuticalLupinMergers & Acquisitions

Lupin debuts generics of two Watson drugs, NOR-QD and Fortamet, in USA

16-10-2011

Indian drugmaker Lupin (500257. BY) last week revealed that it had launched generic versions in the USA…

DiabetesFortametGenericsLupinMarkets & MarketingNor-QDNorth AmericaPatentsReproductiveShionogiWatson Pharmaceuticals

Back to top